These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1177 related items for PubMed ID: 17457124

  • 1. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics.
    Sparr HJ, Vermeyen KM, Beaufort AM, Rietbergen H, Proost JH, Saldien V, Velik-Salchner C, Wierda JM.
    Anesthesiology; 2007 May; 106(5):935-43. PubMed ID: 17457124
    [Abstract] [Full Text] [Related]

  • 2. Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial.
    Pühringer FK, Rex C, Sielenkämper AW, Claudius C, Larsen PB, Prins ME, Eikermann M, Khuenl-Brady KS.
    Anesthesiology; 2008 Aug; 109(2):188-97. PubMed ID: 18648227
    [Abstract] [Full Text] [Related]

  • 3. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD, Driessen JJ, Marcus MA, Kerkkamp H, Heeringa M, Klimek M.
    Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
    [Abstract] [Full Text] [Related]

  • 4. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients.
    Plaud B, Meretoja O, Hofmockel R, Raft J, Stoddart PA, van Kuijk JH, Hermens Y, Mirakhur RK.
    Anesthesiology; 2009 Feb; 110(2):284-94. PubMed ID: 19194156
    [Abstract] [Full Text] [Related]

  • 5. Reversal of neuromuscular blockade by sugammadex after continuous infusion of rocuronium in patients randomized to sevoflurane or propofol maintenance anesthesia.
    Rex C, Wagner S, Spies C, Scholz J, Rietbergen H, Heeringa M, Wulf H.
    Anesthesiology; 2009 Jul; 111(1):30-5. PubMed ID: 19512873
    [Abstract] [Full Text] [Related]

  • 6. Reversal of profound neuromuscular block by sugammadex administered three minutes after rocuronium: a comparison with spontaneous recovery from succinylcholine.
    Lee C, Jahr JS, Candiotti KA, Warriner B, Zornow MH, Naguib M.
    Anesthesiology; 2009 May; 110(5):1020-5. PubMed ID: 19387176
    [Abstract] [Full Text] [Related]

  • 7. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O, White PF, Tufanogullari B, Klein K.
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [Abstract] [Full Text] [Related]

  • 8. The effect of residual neuromuscular blockade on the speed of reversal with sugammadex.
    White PF, Tufanogullari B, Sacan O, Pavlin EG, Viegas OJ, Minkowitz HS, Hudson ME.
    Anesth Analg; 2009 Mar; 108(3):846-51. PubMed ID: 19224792
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetic-pharmacodynamic model for the reversal of neuromuscular blockade by sugammadex.
    Ploeger BA, Smeets J, Strougo A, Drenth HJ, Ruigt G, Houwing N, Danhof M.
    Anesthesiology; 2009 Jan; 110(1):95-105. PubMed ID: 19104176
    [Abstract] [Full Text] [Related]

  • 10. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.
    Khuenl-Brady KS, Wattwil M, Vanacker BF, Lora-Tamayo JI, Rietbergen H, Alvarez-Gómez JA.
    Anesth Analg; 2010 Jan 01; 110(1):64-73. PubMed ID: 19713265
    [Abstract] [Full Text] [Related]

  • 11. Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study.
    Sorgenfrei IF, Norrild K, Larsen PB, Stensballe J, Ostergaard D, Prins ME, Viby-Mogensen J.
    Anesthesiology; 2006 Apr 01; 104(4):667-74. PubMed ID: 16571960
    [Abstract] [Full Text] [Related]

  • 12. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine.
    Jones RK, Caldwell JE, Brull SJ, Soto RG.
    Anesthesiology; 2008 Nov 01; 109(5):816-24. PubMed ID: 18946293
    [Abstract] [Full Text] [Related]

  • 13. Cochrane corner: sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
    Abrishami A, Ho J, Wong J, Yin L, Chung F.
    Anesth Analg; 2010 Apr 01; 110(4):1239. PubMed ID: 20357160
    [Abstract] [Full Text] [Related]

  • 14. A temporary decrease in twitch response during reversal of rocuronium-induced muscle relaxation with a small dose of sugammadex.
    Eleveld DJ, Kuizenga K, Proost JH, Wierda JM.
    Anesth Analg; 2007 Mar 01; 104(3):582-4. PubMed ID: 17312212
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of sugammadex for the reversal of moderate and deep rocuronium-induced neuromuscular block in patients pretreated with intravenous magnesium: a randomized controlled trial.
    Czarnetzki C, Tassonyi E, Lysakowski C, Elia N, Tramèr MR.
    Anesthesiology; 2014 Jul 01; 121(1):59-67. PubMed ID: 24608361
    [Abstract] [Full Text] [Related]

  • 16. Reversal of rocuronium-induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane.
    Vanacker BF, Vermeyen KM, Struys MM, Rietbergen H, Vandermeersch E, Saldien V, Kalmar AF, Prins ME.
    Anesth Analg; 2007 Mar 01; 104(3):563-8. PubMed ID: 17312209
    [Abstract] [Full Text] [Related]

  • 17. Efficacy, safety, and pharmacokinetics of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in elderly patients.
    McDonagh DL, Benedict PE, Kovac AL, Drover DR, Brister NW, Morte JB, Monk TG.
    Anesthesiology; 2011 Feb 01; 114(2):318-29. PubMed ID: 21239968
    [Abstract] [Full Text] [Related]

  • 18. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia.
    Duvaldestin P, Kuizenga K, Saldien V, Claudius C, Servin F, Klein J, Debaene B, Heeringa M.
    Anesth Analg; 2010 Jan 01; 110(1):74-82. PubMed ID: 19933538
    [Abstract] [Full Text] [Related]

  • 19. Sugammadex: another milestone in clinical neuromuscular pharmacology.
    Naguib M.
    Anesth Analg; 2007 Mar 01; 104(3):575-81. PubMed ID: 17312211
    [Abstract] [Full Text] [Related]

  • 20. Reversal of profound rocuronium or vecuronium-induced neuromuscular block with sugammadex in isoflurane-anaesthetised dogs.
    Mosing M, Auer U, West E, Jones RS, Hunter JM.
    Vet J; 2012 Jun 01; 192(3):467-71. PubMed ID: 22030475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.